Pharmaxis Ltd (ASX:PXS) Share Price and News - StockTrack

Market Cap (9-Feb) $19,510,578 (1,113th)	Close (30-Jun) $0.049 0 (0%)	Volume (30-Jun) 1,094,468	Shortsold (12-Jul) 1 (0.00%) (672nd)
52w High $0.000	52w Low $0.000	P/E 20.45	EPS -0.02

	Subject
	PXS PXS Ann: Appendix 4C - quarterly
	1 (current) 2 3
	PXS PXS Ann: Appendix 2A - Exercise of Employee Options
	PXS PXS Ann: Section 708A(5)(e) Notice
	PXS PXS Ann: Becoming a substantial holder
	PXS PXS Ann: Appendix 2A
	PXS PXS Ann: Sale of Russian Distribution Rights
	PXS PXS Ann: Investor Presentation Capital Raising and Growth Outlook
	PXS PXS Ann: Proposed issue of Securities - PXS
	PXS PXS Ann: Placement
	PXS PXS Ann: Trading Halt
	PXS PXS Ann: Investor Presentation
	PXS PXS Ann: Appendix 2A - Exercise of Employee Options
	PXS PXS Ann: Clinical Trial of Treatment to Prevent Wound and Burns Scars
	PXS PXS Ann: US Commercial Launch of Bronchitol
	PXS PXS Ann: First Patient Enrolled - Clinical Trial for Cancer Treatment
	PXS PXS Ann: Appendix 2A - Exercise of Employee Options
	PXS PXS Ann: Half Yearly Report and Accounts
	PXS PXS Ann: Pharmaxis Exports CF Drug to US - US$3 Million Milestone
	PXS PXS Ann: Appendix 4C - quarterly
	PXS PXS Ann: Quarterly Activity Report - December 2020
	PXS PXS Ann: Pharmaxis Receives US$7m milestone from Chiesi
	PXS PXS Ann: Appendix 2A - exercise of employee options
	PXS PXS Ann: Pharmaxis to Present at Proactive CEO Investor Session
	PXS PXS Ann: Change in substantial holding
	PXS PXS Ann: Change of Director's Interest Notice
	PXS PXS Ann: Change of Director's Interest Notice
	PXS PXS Ann: Appendix 3G - Employee Options
	PXS PXS Ann: Appendix 3G - Employee Options
	PXS PXS Ann: Results of Meeting
	PXS PXS Ann: Results of Meeting
	PXS PXS Ann: CEO Presentation to AGM
	PXS PXS Ann: CEO Presentation to AGM
	PXS PXS Ann: Chairman's Address to Shareholders
	PXS PXS Ann: Chairman's Address to Shareholders
	PXS PXS Ann: Ceasing to be a substantial holder from Arix Bioscience
	PXS PXS Ann: MEDIA RELEASE BRONCHITOL FDA and MF Trial
	PXS PXS Ann: Investor Presentation
	PXS PXS Ann: Investor Teleconference
	PXS PXS Ann: Pharmaxis Prioritises Clinical Program on Myelofibrosis
	PXS PXS Ann: FDA Approves Bronchitol for US Market
	PXS PXS Ann: Appendix 4C - quarterly
	PXS PXS Ann: September Quarter 2020 Activity Report
	PXS PXS Ann: Change in substantial holding from Arix Bioscience
	PXS PXS Ann: Change in substantial holding
	PXS PXS Article: ASX to open lower but Nasdaq races to another record

Similar Companies

Cann Group

CAN

Creso Pharma

CPH

Ecofibre

EOF

Incannex Healthcare

IHL

Medical Developments International

MVP

Mayne Pharma Group

MYX

Neuren Pharmaceuticals

NEU

Probiotec

PBP

Recce Pharmaceuticals Ltd

RCE

Starpharma Holdings

SPL

End of Day Prices

Date	Close	Volume	Change
08-Feb	$0.02	2,313,063	0.00 (0.00%)
07-Feb	$0.02	88,549	0.00 (0.00%)
06-Feb	$0.02	185,399	0.00 (0.00%)
05-Feb	$0.02	527,551	0.00 (0.00%)
02-Feb	$0.02	762,847	+0.00 (5.00%)
01-Feb	$0.02	1,829,174	+0.00 (5.26%)
31-Jan	$0.02	3,202,962	0.00 (0.00%)
30-Jan	$0.02	1,188,895	+0.00 (11.76%)
29-Jan	$0.02	637,140	0.00 (0.00%)
25-Jan	$0.02	788,861	0.00 (0.00%)
24-Jan	$0.02	881,505	0.00 (5.56%)
23-Jan	$0.02	636,016	+0.00 (5.88%)
22-Jan	$0.02	78,661,135	0.00 (0.00%)
19-Jan	$0.02	52,375	0.00 (0.00%)
18-Jan	$0.02	1,295,388	0.00 (10.53%)
4 up, 2 down, and 9 flat days

High $0.05	Low $0.04	Trades 74	Turnover $48,318	Volume 1,094,468
30 June 2023 at 4:10pm

High $0.05	Low $0.04	Trades 74	Turnover $48,318	Volume 1,094,468
30 June 2023 at 4:10pm

Pharmaxis Ltd Health Care

$0.049 0.007 (16.67%)

$0.049 0.007 (16.67%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices